Ferrone S - Search Results

1

Immunotherapy of cancer in 2012.

Kirkwood JM, Butterfield LH, Tarhini AA, Zarour H, Kalinski P, Ferrone S. Kirkwood JM, et al. Among authors: ferrone s. CA Cancer J Clin. 2012 Sep-Oct;62(5):309-35. doi: 10.3322/caac.20132. Epub 2012 May 10. CA Cancer J Clin. 2012. PMID: 22576456 Free PMC article. Review.

2

Immunotherapy of malignant diseases. Challenges and strategies.

Ko EC, Wang X, Ferrone S. Ko EC, et al. Among authors: ferrone s. Int Arch Allergy Immunol. 2003 Dec;132(4):294-309. doi: 10.1159/000074897. Int Arch Allergy Immunol. 2003. PMID: 14707461 Review.

3

Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b.

Wang W, Edington HD, Rao UN, Jukic DM, Land SR, Ferrone S, Kirkwood JM. Wang W, et al. Among authors: ferrone s. Clin Cancer Res. 2007 Mar 1;13(5):1523-31. doi: 10.1158/1078-0432.CCR-06-1387. Clin Cancer Res. 2007. PMID: 17332298 Clinical Trial.

4

Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus.

Vujanovic L, Whiteside TL, Potter DM, Chu J, Ferrone S, Butterfield LH. Vujanovic L, et al. Among authors: ferrone s. Cancer Immunol Immunother. 2009 Jan;58(1):121-33. doi: 10.1007/s00262-008-0533-2. Epub 2008 May 17. Cancer Immunol Immunother. 2009. PMID: 18488218 Free PMC article.

5

Monoclonal antibodies for cancer immunotherapy.

Weiner LM, Dhodapkar MV, Ferrone S. Weiner LM, et al. Among authors: ferrone s. Lancet. 2009 Mar 21;373(9668):1033-40. doi: 10.1016/S0140-6736(09)60251-8. Lancet. 2009. PMID: 19304016 Free PMC article. Review.

6

PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients.

Fourcade J, Kudela P, Sun Z, Shen H, Land SR, Lenzner D, Guillaume P, Luescher IF, Sander C, Ferrone S, Kirkwood JM, Zarour HM. Fourcade J, et al. Among authors: ferrone s. J Immunol. 2009 May 1;182(9):5240-9. doi: 10.4049/jimmunol.0803245. J Immunol. 2009. PMID: 19380770 Free PMC article.

7

Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross-presenting function.

López-Albaitero A, Mailliard R, Hackman T, Andrade Filho PA, Wang X, Gooding W, Ferrone S, Kalinski P, Ferris RL. López-Albaitero A, et al. Among authors: ferrone s. J Immunother. 2009 Jun;32(5):465-73. doi: 10.1097/CJI.0b013e3181a1c24e. J Immunother. 2009. PMID: 19609238 Free PMC article.

8

CSPG4 in cancer: multiple roles.

Wang X, Wang Y, Yu L, Sakakura K, Visus C, Schwab JH, Ferrone CR, Favoino E, Koya Y, Campoli MR, McCarthy JB, DeLeo AB, Ferrone S. Wang X, et al. Among authors: ferrone s, ferrone cr. Curr Mol Med. 2010 Jun;10(4):419-29. doi: 10.2174/156652410791316977. Curr Mol Med. 2010. PMID: 20455858 Review.

9

Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape.

Ferris RL, Jaffee EM, Ferrone S. Ferris RL, et al. Among authors: ferrone s. J Clin Oncol. 2010 Oct 1;28(28):4390-9. doi: 10.1200/JCO.2009.27.6360. Epub 2010 Aug 9. J Clin Oncol. 2010. PMID: 20697078 Free PMC article. Review.

10

CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer.

Wang X, Osada T, Wang Y, Yu L, Sakakura K, Katayama A, McCarthy JB, Brufsky A, Chivukula M, Khoury T, Hsu DS, Barry WT, Lyerly HK, Clay TM, Ferrone S. Wang X, et al. Among authors: ferrone s. J Natl Cancer Inst. 2010 Oct 6;102(19):1496-512. doi: 10.1093/jnci/djq343. Epub 2010 Sep 17. J Natl Cancer Inst. 2010. PMID: 20852124 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

937 results

Search Page